[ad_1]
Fintel reports that on April 21, 2023, Benchmark initiated coverage of OmniAb (NASDAQ:OABI) with a Buy recommendation.
Analyst Price Forecast Suggests 203.06% Upside
As of April 6, 2023, the average one-year price target for OmniAb is $10.88. The forecasts range from a low of $8.08 to a high of $13.65. The average price target represents an increase of 203.06% from its latest reported closing price of $3.59.
See our leaderboard of companies with the largest price target upside.
The projected annual revenue for OmniAb is $74MM, an increase of 25.88%. The projected annual non-GAAP EPS is -$0.21.
What are Other Shareholders Doing?
DCCAX – Delaware Small Cap Core Fund holds 2,863K shares representing 2.48% ownership of the company.
TLSTX – Stock Index Fund holds 1K shares representing 0.00% ownership of the company.
Orchard Capital Managment holds 1,280K shares representing 1.11% ownership of the company.
Alliancebernstein holds 101K shares representing 0.09% ownership of the company.
DFAC – Dimensional U.S. Core Equity 2 ETF holds 103K shares representing 0.09% ownership of the company.
What is the Fund Sentiment?
There are 336 funds or institutions reporting positions in OmniAb. This is an increase of 325 owner(s) or 2,954.55% in the last quarter. Average portfolio weight of all funds dedicated to OABI is 0.08%, a decrease of 13.63%. Total shares owned by institutions increased in the last three months by 1,930.06% to 82,178K shares. 
The put/call ratio of OABI is 0.31, indicating a bullish outlook.
See all OmniAb regulatory filings.
This story originally appeared on Fintel.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
[ad_2]
Source link
